Navigation Links
Prime Therapeutics Announces Blue Cross and Blue Shield of Montana as a Pharmacy Benefit Services Client
Date:12/10/2008

ST. PAUL, Minn., Dec. 10 /PRNewswire/ -- Prime Therapeutics LLC (Prime) announces that it has been chosen by Blue Cross and Blue Shield of Montana (BCBSMT) to provide commercial pharmacy benefit management services, beginning January 1, 2009.

Prime will provide pharmacy benefit services to more than 175,000 BCBSMT members enrolled in health plans that include prescription drug coverage. The three-year contract covers a range of pharmacy benefit services including: claims processing, clinical programs, formulary administration, manufacturer contracting, member services, pharmacy network management, prescription mail service and specialty services. In addition, Prime will continue to provide Medicare Part D administration for BCBSMT, a service it has been providing for the health plan since 2006.

Key factors influencing the selection of Prime included the Blues-owned PBM's ability to provide supreme attention to member services and its integrated medical and pharmacy capabilities as well as its industry-unsurpassed customer satisfaction ratings. "Prime's reputation for strong customer service and pharmacy expertise were important factors in our decision," said Blue Cross and Blue Shield of Montana President and Chief Executive Officer Sherry Cladouhos. "As a Blues-owned PBM, we are relying on Prime to deliver the service-oriented, reliable programs Blue Cross and Blue Shield of Montana strives to offer in all our services."

"Prime welcomes Blue Cross and Blue Shield of Montana's business. Our operational scalability and innovative pharmacy approach positions us to efficiently add Blue Cross and Blue Shield of Montana to our growing family of Blues clients," said Tim Dickman, Prime's President and Chief Executive Officer. "The value of an integrated, in-house pharmacy continues to provide the aligned, full service solution that our Blues partners are seeking."

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 10 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.

Blue Cross Blue and Shield of Montana, an independent licensee of the Blue Cross and Blue Shield Association, is Montana's leading not-for-profit health services corporation. Headquartered in Helena, MT, it has conducted business for more than 65 years exclusively in Montana. It serves more than 240,000 members across the state and another 70,000 nationwide through BlueCard. More information is available at http://www.bcbsmt.com.


'/>"/>
SOURCE Prime Therapeutics LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Lab Series(R) Skincare For Men Spa Indulges the 2007 Primetime Emmy(R) Nominees at the Sofitel(R) Los Angeles
3. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
4. Prime Therapeutics Announces URAC Accreditation
5. Prime Minister views innovative health technology at Imperial College London
6. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
7. Prime Healthcare Services Acquires Centinela Hospital Medical Center
8. Activist Groups Plea to Indian Prime Minister: Rollout Second-Line AIDS Treatment!
9. Announcing Prime Vendor Contract with LIHPA
10. Safety Concerns Prompt Prime to Remove Avandia(R) from Formulary
11. Fetal Alcohol Exposure May Prime Offspring for Alcoholism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , ... March 23, 2017 , ... ... of SmartBen NOW, an innovative mobile app and centralized benefits dashboard solving one ... critical information securely from multiple locations. For the first time, employees can access ...
(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home ... world to manage stress and anxiety. , “Buzzies change the way we interact ... co-founder of Buzzies. , Since its launch date in December 2016, The TouchPoint Solution ...
(Date:3/23/2017)... ... 23, 2017 , ... Altec Products, Inc. , a ... their 2016 Microsoft Dynamics Partner of the Year at DocLink Evolution , ... recognizes The Resource Group for their outstanding relationship with Altec and their ability ...
(Date:3/23/2017)... ... March 23, 2017 , ... According to the National ... sleep is likely not the only cause of the sunken-eye look, which can include ... look older or in poor health are likely due to genetics, dehydration, allergies, and ...
(Date:3/23/2017)... El Segundo, CA (PRWEB) , ... March 23, ... ... Verisys FACIS Monthly Monitoring Healthcare products at competitive pricing. ... primary source sanctions, Exclusions, Debarments, License restrictions and Disciplinary actions. , “We are ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017  Ethicon* today ... Medical, Inc., a privately held medical device company ... System for the surgical treatment of Gastroesophageal Reflux ... strategy of expanding its portfolio of minimally invasive ... medical conditions. Financial terms of the transaction have ...
(Date:3/23/2017)... , March 23, 2017 CENTRO DE ... article 157, paragraph 4 of Law 6,404/76 and Instruction ... hereby informs its shareholders and the market in general ... its subsidiary Centro de Diagnosticos por Imagem Ltda. (" ... 100% interest in RADIOLOGISTAS ASSOCIADOS LTDA. (" Partnership " ...
(Date:3/23/2017)... 23, 2017  A new genetic test has ... of individuals who carry HLA-B*15:02 and ... yet potentially deadly side effect of certain medications ... gene HLA-B*15:02 is strongly associated with ... syndrome and toxic epidermal necrolysis in patients treated ...
Breaking Medicine Technology: